Stay updated on PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial

Sign up to get notified when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The completed PADA-1 clinical trial record is displayed, including its study design, eligibility criteria, outcomes, locations, and publications, in place of a 403 Forbidden screen.
    Difference
    85%
    Check dated 2026-11-08T14:44:34.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:50:41.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-25T17:41:37.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.3%
    Check dated 2026-10-18T22:12:24.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.3%
    Check dated 2026-10-11T22:07:15.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A 403 Forbidden error page was added, including the HTML snippet and a 403 title, indicating that access to the study record is blocked and a Home link is provided in the footer. This reflects an access-control issue rather than a content update.
    Difference
    0.5%
    Check dated 2026-09-27T22:23:29.000Z thumbnail image

Stay in the know with updates to PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.